भारत सरकार | Government of India                                                                                                                   Font: Website In - Hindi Language

   National Emblem


National Institute of Biologicals

(राष्ट्रीय जैविक संस्थान)

Ministry of Health & Family Welfare, Government of India

(स्वास्थ्य एवं परिवार कल्याण मंत्रालय,भारत सरकार)

 


Nib Logo



                                                       
Vaccine & Antisera Laboratory

Vaccine Laboratory has been established  to ensure that the vaccines produced, distributed and imported into the country are safe, efficacious and potent with the mandate to evaluate and ensure the quality of Biologicals referred to it.

    

To develop linkage with other national/international institution and keep abreast with worldwide scientific research and technological developments in production and quality control of vaccine with a view to advising on the suitability of their adoption.

 

To develop technical guidelines/ manuals on standards to be used by manufacturers and to undertake research on various immunobiologicals using multidisciplinary integrated approach.  

Providing training facilities in quality control testing of vaccines for personnel of related institutions including testing and manufacturing units and six month dissertation project for post graduate students (M.Sc &B.Tech) of various universities is also formed as an indispensable part of its activities.

 

Vaccine & Antisera Laboratory is notified as CDL for the BCG Vaccine, Cell Culture Rabies Vaccine, Live attenuated Measles Vaccine, Live Attenuated Rubella Vaccine. (Ref. Gazette Notification No: G.S.R. 250 (E) - Part-II - Section 3 - Sub-Section (i) dated 15.03.2017) and Oral Polio Vaccine (Ref. Gazette Notification No: G.S.R. 249 (E), dated: 04.04.2002).

 

Lab has taken up collaborative studies such as inclusion of WHO protocol for Determination of PRP content of Hib (Haemophilus Influenzae type b) in liquid vaccine presentations by HPAEC-PAD in Indian Pharmacopoeia. The purpose of such study was to optimize the protocol for final validation studies and bringing the stakeholders on common consensus for final inclusion of WHO protocol in Indian Pharmacopoeia.

  •  
 

 

REVISED RATES OF TESTING CHARGES / FEE APPROVED AND APPLICABLE W.E.F. 01.06.2016


 

Turnaround time for testing new

Disclaimer          copyright                 Hyperlink Policy                       Terms & Conditions                   Privacy Policy                    accessibility Policy                     WebInfoManager                          Feedback      


This website belongs to "National Institute of Biologicals", Ministry of Health & Family Welfare, Govt. of India.
   Site Designed, Developed and Hosted by National Informatics Centre Services Inc.